Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Aspire Biopharma Holdings
13G/A
Amendment 1
ASBP · 738920107
|
0% |
5/13/2026
Event 12/31/2025
|
|||
| Ardsley Advisory Partners LP | 0% | ||||
| Ardsley Advisory Partners GP LLC | 0% | ||||
| Ardsley Partners I GP LLC | 0% | ||||
| Ardsley Partners Advanced Healthcare Fund, L.P. | 0% | ||||
| Ardsley Partners Fund II, L.P. | 0% | ||||
| Philip J. Hempleman | 0% | ||||
|
Aspire Biopharma Holdings, Inc.
13G
ASBP · 738920107
|
7.8% |
2/12/2026
Event 12/31/2025
|
|||
| Ardsley Advisory Partners LP | 7.8% | ||||
| Ardsley Advisory Partners GP LLC | 7.8% | ||||
| Ardsley Partners I GP LLC | 7.8% | ||||
| Ardsley Partners Advanced Healthcare Fund, L.P. | 6.7% | ||||
| Ardsley Partners Fund II, L.P. | 1.1% | ||||
| Philip J. Hempleman | 7.8% | ||||